Literature DB >> 19013220

Epigenetic states in stem cells.

Philippe Collas1.   

Abstract

Whereas embryonic stem cells can differentiate into all cell types of the body, stem cells found in somatic tissues display more restrictive differentiation capacity. The extent of multi-lineage differentiation ability of stem cells is believed to be associated with the potential for expression of developmentally- and differentiation-regulated genes. Growing evidence suggests that this potential for gene expression in undifferentiated cells is regulated by epigenetic processes on DNA and chromatin in regulatory and coding regions. Genome-wide mapping of DNA methylation profiles and of post-translational histone modifications in stem cells and differentiated cells has led to the establishment of chromatin states primarily on promoters of active, repressed and potentially active genes. These maps contribute to unveiling regulatory mechanisms by which genes are poised for transcription in undifferentiated cells. We summarize here the current view of how specific combinations of epigenetic marks may define the pluripotent state.

Mesh:

Substances:

Year:  2008        PMID: 19013220     DOI: 10.1016/j.bbagen.2008.10.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

Review 1.  Epigenetic choreography of stem cells: the DNA demethylation episode of development.

Authors:  Swayamsiddha Kar; Sabnam Parbin; Moonmoon Deb; Arunima Shilpi; Dipta Sengupta; Sandip Kumar Rath; Madhumita Rakshit; Aditi Patra; Samir Kumar Patra
Journal:  Cell Mol Life Sci       Date:  2013-10-10       Impact factor: 9.261

2.  Nano-hydroxyapatite modulates osteoblast lineage commitment by stimulation of DNA methylation and regulation of gene expression.

Authors:  Shin-Woo Ha; Hae Lin Jang; Ki Tae Nam; George R Beck
Journal:  Biomaterials       Date:  2015-06-23       Impact factor: 12.479

Review 3.  Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors.

Authors:  Stephane Boeuf; Wiltrud Richter
Journal:  Stem Cell Res Ther       Date:  2010-10-13       Impact factor: 6.832

4.  A Method to Study the Epigenetic Chromatin States of Rare Hematopoietic Stem and Progenitor Cells; MiniChIP-Chip.

Authors:  Holger Weishaupt; Joanne L Attema
Journal:  Biol Proced Online       Date:  2010-05-15       Impact factor: 3.244

5.  Genome-wide analysis of the chromatin composition of histone H2A and H3 variants in mouse embryonic stem cells.

Authors:  Masashi Yukawa; Tomohiko Akiyama; Vedran Franke; Nathan Mise; Takayuki Isagawa; Yutaka Suzuki; Masataka G Suzuki; Kristian Vlahovicek; Kuniya Abe; Hiroyuki Aburatani; Fugaku Aoki
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

6.  Knockdown of the HDAC1 promotes the directed differentiation of bone mesenchymal stem cells into cardiomyocytes.

Authors:  Dong-feng Lu; Ying Wang; Zi-zhuo Su; Zhao-hua Zeng; Xiao-wen Xing; Zhi-yu He; Chunxiang Zhang
Journal:  PLoS One       Date:  2014-03-31       Impact factor: 3.240

7.  ROR2 Promoter Methylation Change in Osteoblastic Differentiation of Mesenchymal Stem Cells.

Authors:  Gorbanali Tarfiei; Mehrdad Noruzinia; Masood Soleimani; Saeed Kaviani; Maryam Mahmoodinia Maymand; Majid Farshdousti Hagh; Pascal Pujol
Journal:  Cell J       Date:  2011-04-21       Impact factor: 2.479

8.  Prospective in vitro models of channelopathies and cardiomyopathies.

Authors:  Nanako Kawaguchi; Emiko Hayama; Yoshiyuki Furutani; Toshio Nakanishi
Journal:  Stem Cells Int       Date:  2012-03-27       Impact factor: 5.443

9.  A global genome segmentation method for exploration of epigenetic patterns.

Authors:  Lydia Steiner; Lydia Hopp; Henry Wirth; Jörg Galle; Hans Binder; Sonja J Prohaska; Thimo Rohlf
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

10.  Downregulation of HDAC1 is involved in the cardiomyocyte differentiation from mesenchymal stem cells in a myocardial microenvironment.

Authors:  Dong-feng Lu; Yan Yao; Zi-zhuo Su; Zhao-hua Zeng; Xiao-wen Xing; Zhi-yu He; Chunxiang Zhang
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.